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Abstract 
Pressed chromium-powder cyclotron targets were irradiated with 16 MeV protons, producing 52Mn with 
average yields of 6.2 ± 0.8 MBq/µAh. Separation by solid-phase anion exchange from ethanol-HCl mixtures 
recovered 94.3 ± 1.7% of 52Mn and reduced the chromium content by a factor of 2.2 ± 0.4 × 105. An 
additional AG 1-X8 column was used to remove copper, iron, cobalt and zinc impurities from the prepared 
52Mn in 8 M HCl. The macrocyclic chelator DOTA was rapidly radiolabeled with 52Mn in aq. ammonium 
acetate (pH 7.5 R.T.) with a radiochemical yield >98% within 1 minute and was stable for >2 days in bovine 
serum. The improved separation and purification methodology facilitates the use of 52Mn in basic science 
and preclinical investigations. 
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Introduction 
Manganese is an element essential to living organisms in which it functions as a co-factor in a wide variety 
of enzymes in its divalent state2. Mn2+ enters neurons via voltage gated Ca2+ channels and has, due to its 
paramagnetic properties, been used preclinically as a potent MRI contrast agent for imaging neural activity3. 
In addition, it has been established that manganese enters active beta cells in the islets of Langerhans, thus 
providing the possibility of a non-invasive measure of the functional beta cell mass during the progression of 
diabetes4.  
Manganese, however, is toxic and the maximum amount of injected MRI contrast is therefore severely 
limited5–7. This fact has hindered the use of manganese enhanced MRI (MEMRI) in clinical investigations. 
However, the already well established methods developed in preclinical MEMRI can be readily adapted to 
Positron Emission Tomography (PET) by using 52gMn (from here on 52Mn, t½ = 5.6 days; β+ = 29.4%; Eaveβ+ 
= 242 keV), for which sub-nM concentrations are sufficient for functional imaging, thereby completely 
bypassing the toxicity issues of manganese. 
Currently 89Zr and 64Cu are the common radiometals of choice for labeling proteins with slow distribution 
kinetics8,9. However, for some preclinical and basic science applications 52Mn may be a better choice. It 
provides aqueous chelation chemistry similar to that of 64Cu, omitting the need for hard ligands like oxalate 
which are needed to keep 89Zr chemically accessible, while having a higher β+ branch as well as a longer 
half-life than both 64Cu (17.6% β+, T½ = 12.7 h) and 89Zr (22.7% β+, T½ = 3.3 days). In PET imaging of small 
animals, image resolution is a critical in order to allow discrimination of different regions of interest. The 
primary factor limiting the resolution is the energy of the emitted positron10. In principle, the lower average 
β+ energy of 52Mn (242 keV for 52Mn versus 396 keV for 89Zr) will result in PET resolution superior to 89Zr. 
Despite its facile chelation chemistry and attractive imaging properties, limited work has been reported on 
the separation chemistry and labeling with 52Mn. This is probably a consequence of the somewhat 
discouraging dosimetry associated with the multiple high energy, high abundance gamma emissions of 52Mn 
(744, 936 and 1434 keV) as seen in figure 1. This, however, only has significance if the purpose of the study 
is translational tracer design. In drug development, the dosimetry is less relevant, because the radioisotope is 
not intended to be part of the final drug product, but only used as a means to gather crucial information about 
drug kinetics, biodistribution, route of metabolization and excretion, etc. 
  
Figure 1: A simplified decay scheme for 52gMn11.  
 
Detailed work on production cross-sections of the natCr(p,x)52Mn reaction has demonstrated that the reaction 
is highly capable of providing sufficient amounts of 52Mn for imaging applications12,13. Recently, Buchholz 
et al. reported a separation method based on solid phase extraction of manganese from acid/organic solvent 
mixtures14. The results presented in the present study are an improvement on a conceptually similar method 
recently published by this group1, demonstrating improved separation efficiency without compromising the 
decrease in chromium content. One major improvement on previously published work is the introduction of 
a remediation column, which efficiently removes non-radioactive metal-ion impurities that would otherwise 
hinder high specific activity labeling. The improved method is still time efficient and can be performed in 
less than 4 h. Additionally, optimized labeling conditions with the chelator DOTA (1,4,7,10-
tetraazacyclododecane-1,4,7,10-tetraacetic acid) and the bioconjugate DOTA-(Tyr3)-octreotate (DOTA-
TATE) are explored and reported. Serum stability studies of the 52Mn-DOTA complex demonstrate the 
suitability of the chelator for in vivo studies. 
The work presented in this paper describes tested and optimized procedures for production and purification, 
as well as labeling with 52Mn produced on a small medical cyclotron. 
 
Materials and Methods 
 
General experimental details 
Unless otherwise stated, all chemicals were purchased from Sigma Aldrich. Chromium powder (100 - 325 
mesh, 99.99% purity) was obtained from Alfa-Aesar. Hydrochloric acid (aq. HCl ≥ 37%, TraceSelect, Fluka) 
was titrated and found to be 11.3 M. All other concentrations of HCl used, were prepared from this batch by 
dilution with TraceSELECT water (Fluka). All other water was Milli-Q grade (Sartorius Arium 611VF, σ = 
0.055 µS/cm). 
100 g of AG 1-X8 anion exchange resin in the formate form (8% cross-linked with divinyl benzene, 200 - 
400 mesh, Bio-Rad) was converted to its chloride form by rinsing with 20 bed volumes of 2 M aq. HCl and 
washing with Milli-Q water until the effluent was neutral pH. Afterwards the resin was washed with ethanol 
(≥ 99.8%, Fluka) and dried at 20°C. 
Thin-layer chromatography (TLC) was performed on aluminum-backed silica (Merck TLC silica gel 60 
F254) and eluted with 5% (w/v) ammonium acetate in a 1:1 mixture of methanol and water. In this system, 
the Rf values were determined to be 0.30-0.35 for Mn-DOTA and 0.4-0.5 for Mn-DOTA-TATE, while un-
chelated Mn2+ remains at the origin. TLC plates were analyzed by autoradiography on a Cyclone Plus 
Storage Phosphor Scanner (PerkinElmer) and data analysis was performed using the OptiQuant software 
(PerkinElmer).  
52Mn samples in excess of 1 MBq were quantified with a Capintec CRC-55tR dose calibrator using the 
manufacturer's recommended calibration number “676/2”. Low activity samples of 52Mn, 54Mn, and all 51Cr 
samples were quantified using either liquid scintillation counting (LSC) on a HIDEX 300 SL or by gamma 
spectroscopy a Ge(Li) detector (Princeton Gammatech LGC 5) calibrated using certified 133Ba and 152Eu 
calibration standards. The obtained gamma spectra were processed using the Genie 2000 software 
(Canberra). 
Trace metals were quantified by ICP-OES (inductively coupled plasma optical emission spectroscopy) using 
a ThermoScientific iCAP 6000 Series instrument with iTeva software. The spectrometer was calibrated 
against standard solutions containing Cr, Mn, Co, Fe, Zn and Cu, which were prepared by dissolution and 
dilution of chloride salts of the tested metals in 0.3 M HCl. Samples for analysis were likewise diluted in 0.3 
M HCl. 
 
Cyclotron targetry and irradiation 
The targets were prepared by pressing 90-273 mg of chromium powder onto the surface of a 1 mm thick Ø = 
29 mm silver disc using a metal powder pressing mold, ensuring centering of the Ø = 13 mm pressed 
chromium pellets. The pressing was done using a mechanical press at 7500 kg/cm2 of pressure (10000 kg, Ø 
= 13 mm) resulting in approximate target thicknesses in the range of 68-206 mg/cm2. The disc was covered 
with an either 12.5 µm or 25 µm niobium front foil and mounted on a beam port on a GE PETtrace 800 
cyclotron, providing direct water cooling on the rear face of the silver disc. The target was irradiated at a 
beam current of 20 µA with an incident energy of 16 MeV for 80-400 minutes resulting in integrated 
currents of 28-128 µAh. 52Mn was produced primarily via the 52Cr(p,n)52Mn reaction, with a small 
contribution from the less abundant 53Cr via 53Cr(p,2n)52Mn, by proton irradiation of naturally abundant 
chromium. The 2.36% abundant 54Cr gave rise to co-production of small amounts of 54Mn via the 
54Cr(p,n)54Mn reaction. 
 
Determination of separation conditions 
In order to determine the optimal acid:ethanol ratio for selective solid phase extraction of manganese from 
chromium onto AG 1-X8 resin, distribution coefficients of Cr3+ and Mn2+ on AG 1-X8 were determined in 
mixtures of aqueous HCl (conc. range: 3.8-11.3 M) and absolute ethanol, mixed in a range of 2-7% (v/v) aq. 
HCl in ethanol. A total of 18 different conditions were tested by adding 100 ± 2 mg of AG 1-X8 resin to 5 
mL of each of the acid:ethanol ratios, all containing 100 kBq 52Mn and 250 µg natCr. The resulting mixtures 
were agitated periodically over the course of several hours at room temperature, and after settling for 72 h 
they were re-agitated and finally allowed to settle for a further hour. 100 µL samples of the supernatants 
were removed for measurement by ICP-OES to determine the Cr-content and liquid scintillation counting to 
determine the 52Mn content. The data were analyzed by comparison to Cr and 52Mn containing standards 
prepared without resin. 
 
 
 
Separation 
Following bombardment, the irradiated target was left on the cyclotron for at least 2 hours to allow the decay 
of 52mMn (t1/2 = 20 min). After disassembling the target holder, the target disc was submerged in 11.3 M HCl 
and either left overnight at room temperature or on a heating block at 90-100 ˚C for approx. 30 min to 
dissolve the chromium. The entire dissolution was taken almost to dryness at 150 ˚C (either with or without 
nitrogen flow) and redissolved in aq. HCl (1.5 mL, 11.3 M. This solution was diluted in absolute ethanol 
(48.5 mL), bringing the final concentration to 3% (v/v) 11.3 M HCl in absolute ethanol. This was led through 
a thin (Ø = 4 mm) AG 1-X8 column (300 mg), equilibrated by washing with 5 ml 0.1 M HCl, 10 mL water 
and 5 mL of 3% (v/v) 11.3 M HCl in absolute ethanol, retaining the 52Mn on the column. The loaded column 
was washed with 25 mL of 3% (v/v) 11.3 M HCl in absolute ethanol and the 52Mn was eluted in 2 mL of 0.1 
M HCl. This entire procedure was then repeated twice for a total of three iterations (figure 2). In the second 
and third iteration however, the dry activity was redissolved in only 300 µL 11.3 M HCl and mixed with 9.7 
mL of absolute ethanol. Because of the markedly reduced overall metal content after the first column, the 
resin mass used in the second and third column was reduced to 200 mg and 100 mg, respectively. 
 
Figure 2: Flowchart illustrating the separation process. 
 
 
Trace Metal Content and Remediation 
After each separation repetition, samples were taken for ICP-OES analysis to determine the separation 
efficiency. The analytical concentrations of chromium and manganese were determined, as well as the 
common impurities iron, copper, cobalt, and zinc. 50 µL or 100 µL of sample material were diluted to 5-10 
mL with 0.3 M HCl in 15 mL metal free PP centrifuge tubes (VWR) before analysis. The separation 
efficiency was determined from the calculated chromium content. The specific activity was calculated using 
the Mn content as determined by ICP-OES. 
As contaminant metals will vary depending on target material and reagent stocks, we implemented a short 
procedure for removal of the unwanted metal ions of iron, zinc, copper, and cobalt. For this procedure, a 
sample of 52Mn (in 0.1M HCl) from after the third separation column, was dried down and then redissolved 
in 1 mL 8 M HCl. This was passed over 500 mg AG 1-X8 resin (pre-equilibrated in 8 M HCl) and the 
effluent containing the 52Mn, along with a wash volume of an additional 2 mL of 8 M HCl, were collected 
and the metal content determined using ICP-OES. 
 
Chelation chemistry 
52Mn in 0.1M HCl was dried on a heating block under a stream of either argon or nitrogen (5-7 minutes at 
130 oC). When cooled to ambient temperature, a solution of DOTA in aq. ammonium acetate buffer (1.00 
mL, DOTA: 50 µM, ammonium acetate: 100 mM), adjusted to pH 4.5, 6.0 or 7.5 using HCl/NaOH, was 
added to the dry 52Mn. The resulting mixtures were stirred at either room temperature (RT) or 55 °C and 
analyzed at specified time-points by radio-TLC. In addition, after 15 min or 30 min, one tenth of the volume 
(100 µL) was removed and the aspirated radioactivity was compared to the radioactivity left in the vial, in 
order to confirm that all of the 52Mn was present in the aqueous phase. Under identical conditions, solutions 
of DOTA-TATE in ammonium acetate buffer (1.00 mL, DOTA-TATE: 50 µM, ammonium acetate 100 mM, 
pH = 7.4) were added to vials containing dry 52Mn and the reactions were monitored over time using radio-
TLC.  
 
Serum stability 
Two vials containing purified 52Mn in 0.1 M HCl were dried under nitrogen flow at 130 oC. After cooling to 
room temperature, the 52Mn in one vial was redissolved in isotonic HEPES buffer (10 mM HEPES, 150 mM 
NaCl, pH = 7.4) to a radioactivity concentration of 13 MBq/mL. The 52Mn in the other vial was redissolved 
in isotonic HEPES buffer containing 25 µM DOTA, likewise to a concentration of 13 MBq/mL. Radio-TLC 
after 5 minutes confirmed that all 52Mn in the DOTA-containing solution was present as Mn-DOTA.  Using 
100 µL aliquots of these stocks, four different 1 mL preparations of 52Mn were produced by dilution with 
whole fetal bovine serum (Sigma Aldrich) and isotonic HEPES buffer: 52Mn-DOTA in 75% bovine serum, 
52Mn in 75% bovine serum, 52Mn-DOTA in isotonic HEPES buffer and 52Mn in isotonic HEPES buffer. 
After incubation at 37 ˚C for 2 days, the mixtures were applied to PD-10 size exclusion cartridges (GE 
Healthcare), eluted with isotonic HEPES and collected in 1 mL fractions. The radioactivity in the collected 
fractions was measured, and the peak fractions from the DOTA-containing samples were analyzed by radio-
TLC to assess whether the Mn-DOTA complex was still intact. 
 
 
 
 
 
Results 
 
Cyclotron targetry and irradiation 
None of the irradiated targets showed visible signs of thermal damage after irradiation. The production yields 
for 52Mn ranged from 4.87-7.43 MBq/µAh, while 51Cr production rates ranged from 0.29-0.39 MBq/µAh. 
Considering that 52mMn has a very short half-life and that 51Cr is separated along with the bulk natCr, the only 
isotope that could appear as a contaminant after purification is 54Mn (T½ = 312.1 days), which was produced 
at an approximate rate of 7.4 kBq/µAh.  
 
Determination of separation conditions 
Batch mode experiments were performed to determine the distribution coefficients of both Mn2+ and Cr3+ on 
the anion exchange resin AG 1-X8 in a range of 2-7% (v/v) 3.8-11.3 M HCl in absolute ethanol (figure 2). 
The measurements revealed an increase in Mn2+ extraction with increasing ethanol concentration as well as 
with increasing molarity of the acid. Under many of the conditions sampled, the measured distribution 
coefficient of manganese exceeded 1000 mL/g, which is sufficiently high to design trap-and-release 
extraction on small resin beds. The results showed a slight up-concentration of Cr3+ to the solid phase from 
the solvent mixture, but always in a range of 0.5-10 mL/g (figure 2).   
 
Figure 2. Graph showing the distribution coefficients for Mn2+ (solid markers) and Cr3+ (open markers) on 
AG 1-X8 resin from ethanol with various volumes and concentrations of aqueous hydrochloric acid. The x-
axis percentage is v/v, with the complementary volume comprised of 11.3, 7.5, or 3.8M aq. HCl.   
 
Separation 
Dissolution of the chromium target in 11.3M HCl was very slow at room temperature, but was greatly 
accelerated with heat. Depending on laboratory logistics for the experiments, target dissolutions were either 
heated or not, with no observed disruption of the further chemical separation. Drying the dissolved target 
was time consuming, but was accelerated with nitrogen gas flow. The main purpose of drying the target was 
to obtain a reproducible acid and water content in the separation, and was found necessary to keep the 
processing volume small. It was important at this step not to dry the target material entirely, but to retain it as 
sludge in order to hasten redissolution. Redissolution with 11.3 M HCl was aided by heat, and at the first 
step was >99.5% efficient at re-suspending the 52Mn radioactivity. In preliminary experiments, attempts were 
made to redissolve the dry target mass directly in 3% (v/v) 11.3M HCl in absolute ethanol, but this proved 
unsuccessful. 
 
In the three repetitions of the AG 1-X8 purification, trapping of 52Mn on AG 1-X8 was quantitative, with 
>99.8% of the available activity present on the column after washing. The 52Mn was efficiently eluted 
(>97%) in 2 mL of 0.1 M HCl. After this, the 52Mn-containing solution was dried down in order to reset the 
acid and water content. The largest losses of 52Mn were incurred when attempting to re-solubilize the 
residue, ranging from 0.5-2% losses at each of the two repetitions. Similar to the previous redissolution, we 
found that dissolution of dried down Cr/Mn, was sufficiently efficient in hot 11.3 M HCl, but not possible in 
3% (v/v) 11.3 M HCl in absolute ethanol. 94.3 ± 1.7% of the produced activity was retained after the three 
purification iterations, with an average Cr3+ mass reduction factor of 2.2 ± 0.4 × 105 to an average mass of 
only 607 ng, as determined by ICP-OES (figure 3). 
 
Figure 3: Reduction of the chromium content throughout the separation procedure (n=3). Chromium content 
is given as chromium mass per unit activity of 52Mn, relative to the starting value. Therefore, the value 
shown on the plot for each step is the cumulative decontamination factor at the end of that step.  
 
Trace Metal Content and Remediation 
The specific activity of 52Mn versus non-radioactive manganese content ranged from 16 to 120 GBq/µmol. 
ICP-OES analysis was able to determine which metal impurities were able to follow manganese through the 
purification steps. Other than chromium, the main impurities observed by ICP-OES analysis were iron and 
copper along with zinc and cobalt. These were present in varying amounts on the order of 0.01-1 nmol of 
each per MBq of 52Mn, and could be removed by a final remediation step, in which the 52Mn in 8 M HCl was 
passed over an AG 1-X8 column. As a result of this step, 17% of the 52Mn remained on the AG 1-X8 
column, while the remaining 83% was available for further use from the 8 M HCl. 
Figure 4 shows the content of metal impurities after elution at each step of the separation, and after the final 
remediation column, relative to the amount of each metal that was present after the first column. Clearly, 
copper and cobalt behave similar to Mn in the separation, which is not surprising in light of the data 
presented by Pietrzyk and Fritz, which shows that copper and cobalt have the highest affinity for AG 1-X8 
from partially aqueous HCl solutions of any metals tested15. The sharp decline in the contaminant 
concentration after the final purification step is consistent with the general data from Nelson et al. for metal 
ions against strong anion exchange resin in aqueous HCl16. 
 
Figure 4: Trace metal behavior during the separation and after the remediation column. Values reflect the 
mass of each metal relative to 52Mn radioactivity, normalized to the value after the first separation column. In 
this way, the curve for manganese shows that the specific activity of 52Mn is slowly declining throughout the 
separation process. Evident in the plot is the effectiveness of the remediation column at removing many 
common transition metal impurities from the purified manganese. 
 
 
Chelation chemistry 
52Mn was observed to be rapidly chelated by DOTA in a pH range of 4.5-7.5 and at both room temperature 
and 55 oC (figure 5). At pH 6.0 and 7.5, 52Mn-DOTA was formed with >99% conversion within one minute 
at both tested temperatures. At pH 4.5 the conversion rate was slower, with >99% conversion after 5 minutes 
at 55 oC and >99% conversion after 20 minutes at room temperature. >99% of the dried 52Mn was re-
solubilized in the labeling buffer within 15 minutes in all observed cases, suggesting high solubility of Mn2+ 
at pH 4.5-7.5 in the tested buffer systems. Accordingly, our results show that 52Mn is rapidly chelated by 
DOTA in the pH range of 4.5-7.5 and a temperature range of 20-55 oC. Similarly, the reactions with DOTA-
TATE were efficient and reached >99% completion after 10 min at room temperature. 
 
Figure 5: Chelation of Mn2+ by the macrocyclic chelate DOTA in ammonium acetate buffer for different pH 
values and temperature versus time. 
 
Serum Stability 
The serum stability test showed no indication of 52Mn-DOTA instability or transchelation of 52Mn after 2 
days in bovine serum. As the 52Mn-DOTA in bovine serum was eluted from the PD-10 column, the activity 
elution profile was identical to that of 52Mn-DOTA in isotonic HEPES buffer (figure 6). Subsequent radio-
TLC analysis of the eluted activity showed all activity present at the Rf of 52Mn-DOTA, showing that all 
radioactivity was still in the form of 52Mn-DOTA. The PD-10 elution profiles of 52Mn-DOTA in bovine 
serum, 52Mn-DOTA in buffer, 52Mn in bovine serum and 52Mn in buffer can be seen in figure 6. 52Mn mixed 
with bovine serum is observed to elute in the large-molecule fractions, while 52Mn in buffer eluted in the 
small-molecule fractions. This indicated association of free 52Mn with serum proteins. The elution profiles 
also provide an important reminder of the soft size separation cutoff of the PD-10 columns. Bioconjugation 
procedures commonly include a gel filtration step to remove unconjugated chelator before adding the 
radiometal to be labeled. If chelators are thought of as small molecules this could result in some amount of 
unconjugated chelator being collected in the protein fraction. This will necessarily result in lower labeling 
yields. 
 
 
 
Figure 6: Gel filtration (PD-10) elution profile for 52Mn-DOTA and 52Mn after incubation for two days at 37 
oC with and without bovine serum. The plot documents how un-chelated activity while in serum will elute 
with the large molecule fractions, while when in buffer will elute with the small molecule fractions. 52Mn 
dislocated from DOTA would elute in that manner, but that is not observed proving that the 52Mn-DOTA 
complex is intact.  
 
Discussion 
 
The methodology developed above is optimized for recovery of 52Mn in a small volume of dilute 
HCl.  Improvements in 52Mn extraction from the Cr matrix were made by employing sequentially smaller 
AG 1-X8 resin masses, using a controlled flow rate, and eluting in 0.1M HCl. Although the residual Cr3+ 
content in the final product is slightly higher compared to Graves et al. (reduction factor of 2.2 ± 0.4 × 105 
compared to 1.6 ± 1.0 × 106), the amount is still sufficiently below toxic levels1. Overall, trap and release of 
52Mn using AG 1-X8 anion exchange resin is very efficient, and for the entire process, the largest losses of 
52Mn activity arose when redissolving the dried-down 52Mn with HCl. While, in principle this step could be 
avoided by eluting the columns with a higher concentration of HCl, this would lead to excessively large 
volumes of ethanol/HCl needed for further processing. 
Overall, the column behavior agrees well with the measured distribution coefficients. The highest 
distribution coefficients for Mn2+ were observed at 2% (v:v) 11.3 M HCl in absolute ethanol with values of 
1.06 × 104 mL/g. However, for the separation process, we selected 97% ethanol, because it afforded a more 
easy to handle volume of HCl for redissolving the dried 52Mn, while still keeping the required ethanol 
volume below 10 mL for the second and third separations. Also evident in the Mn distribution coefficients is 
a strong dependence on the HCl concentration, but given the overall high values for 97% ethanol with 7.5 
and 11.3 M HCl, the exact acid concentration seems to be unimportant. The behavior of Cr3+ in this system 
was shown to be relatively independent of the acid and ethanol concentrations. Contaminant metal ions of 
copper, zinc, cobalt and iron were observed to follow manganese through the separation process, but these 
were easily removed by a final cleanup step of passing the collected 52Mn over an AG 1-X8 resin bed in 8 M 
aq. HCl. In instances where bioconjugate chelation can be subverted by competing metals, this extra step 
may prove essential.       
Chelation reactions with DOTA were rapid over a wide pH range (4.5-7.5) when DOTA was present in large 
excess, and Mn-DOTA was shown to be 100% stable in bovine serum for >2 days. DOTA furthermore has 
very low affinity for Cr3+, which makes 52Mn chelation with DOTA insensitive to residual trace Cr after 
separation.  These three points support the use of DOTA as a chelator for stable chelation and bioconjugation 
of 52Mn to long-circulating tracing vectors. 
 
Conclusion: 
The separation method for purifying 52Mn from bulk chromium presented in this paper is robust, efficient, 
and easily adaptable depending upon need. Radiolabeling with the common bioconjugate chelator DOTA is 
rapid and serum stability of the DOTA chelate is excellent, making 52Mn useful for extended time-point PET 
imaging for drug development and pharmacokinetic evaluations. 
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